Silence Therapeutics plc (SLN) Financials
SLN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 115.1 million | 65.7 million |
| Dec. 31, 2025 | 131.4 million | 69.1 million |
| Sept. 30, 2025 | 146.8 million | 72.7 million |
| June 30, 2025 | 165.2 million | 71.1 million |
SLN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -15.6 million | 2.4 million |
| Dec. 31, 2025 | -17.3 million | 7.3 million |
| Sept. 30, 2025 | -10.9 million | 2.5 million |
| June 30, 2025 | -21.8 million | 2.1 million |
SLN Net Income
No data available :(
SLN Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 70.1 million | - | 42999 |
| Dec. 31, 2025 | 85.1 million | - | 71000 |
| Sept. 30, 2025 | 102.2 million | - | 182000 |
| June 30, 2025 | 114.2 million | - | - |
SLN Shares Outstanding
SLN Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 8.3 million | 7.0 million | - |
| Dec. 31, 2025 | 55000 | 8.7 million | 3.7 million | - |
| Sept. 30, 2025 | 3000 | 20.5 million | 5.8 million | - |
| June 30, 2025 | 48000 | 24.2 million | 7.0 million | - |
SLN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 421292 | 116803 |
| Dec. 31, 2025 | 34000 | 12000 |
| Sept. 30, 2025 | 159000 | 64000 |
| June 30, 2025 | 307544 | 85000 |
SLN Revenue by Segment
Graph available only for paid members. Upgrade to see it.
SLN
Price: $6.69
52 week price:
Earnings Per Share: -1.62 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 18800
Market Capitalization: 302.8 million